Th1 Response to Influenza: Aging and Vaccine Efficacy

NCT00396305 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: Placebo
BIOLOGICAL: Trivalent Inactivated Influenza

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)